Gerda Egger is Head of Molecular Pathology at the Ludwig Boltzmann Institute Applied Diagnostics.
She obtained her Diploma in Genetics and PhD in Biochemistry at the University of Vienna. After a 5-year postdoc fellowship in the group of Peter Jones at the University of Southern California (USC), she joined the Clinical Institute of Pathology of the Medical University of Vienna as a postdoc. Since 2014, she was appointed as Associate Professor at the Clinical Institute of Pathology and she holds the venia docendi for tumor biology. She is head of the Epigenetics work group and supervisor within two thematic PhD programmes of the MUW. Further, she is a lector for Epigenetics at the University of Vienna.
GE’s group is focusing on epigenomics of different diseases including cancer. She has a long-standing expertise in genome-wide and locus specific DNA methylation profiling and chromatin analysis. By using both mouse models and primary patient samples she aims to study the relationship of epigenetic alterations and functional biological pathways relevant to tumorigenesis or other complex disease.
She is closely collaborating with clinicians to explore potential epigenetic biomarkers in different disease settings, such as minimal-invasive biomarkers for tumor diagnosis in liquid biopsies. Furthermore, she has established several transgenic mouse models to study the role of epigenetic mechanisms in cancer.
University of Vienna
- Epigenetics- From basic mechanisms to medical applications
- Übung in Genetik und Molekularer Pathologie - Epigenetik
Medical University of Vienna
- Epigenetics - From basic mechanisms to medical applications
- Epigenetik und Tumorbiologie
- BL 8 - Krankheit, Krankheitsursachen und Krankheitsbilder
- TS and PR: (Epi)genetics of malignant diseases
- JC Personalized Medicine, Biomarker and Drug Discovery: current strategies to combat malignant diseases
- Journalclub: Epigenetic Mechanisms in Health and Disease